Article

Platelet proteomic signatures of amyloid b-positive mild cognitive impairment and Alzheimer's disease

2025-11-05

Abstract excerpt

<title>Abstract</title> <p> Early detection of Alzheimer’s disease (AD) is critical for preventing disease progression. Blood platelets have emerged as a useful peripheral source for AD diagnosis. However, the identification of proteomics-based platelet biomarkers of mild cognitive impairment (MCI) and AD in relation to amyloid β (Aβ) deposition remains largely unexplored. In this study, we compared four groups...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c72cb0cf-b486-56e1-95ac-0d0c4eb2fe07
DOI: 10.21203/rs.3.rs-7846564/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Platelet proteomic signatures of amyloid b-positive mild cognitive impairment and Alzheimer's diseaseDOI 10.21203/rs.3.rs-7846564/v1Read

A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype.Semantic proximity Read

The platelet transcriptome and proteome in Alzheimer’s disease and aging: an exploratory cross-sectional studySemantic proximity Read

Proteome-wide association study identifies novel Alzheimer's disease- associated proteinsSemantic proximity Read

Proteomic Insight Into Alzheimer's Disease Pathogenesis PathwaysSemantic proximity Read

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed dementia cohortSemantic proximity Read

Deep Plasma Proteomics Reveals Shared and Disease-Specific Molecular Signatures in Alzheimer’s Disease and Frontotemporal DementiaSemantic proximity Read

Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later lifeSemantic proximity Read

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read

Mapping Post-Translational Modifications in Brain Regions in Alzheimer's Disease Using Proteomics Data MiningSemantic proximity Read

High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort.Semantic proximity Read

Cerebrospinal Fluid (CSF) Proteomic Signature in Preclinical and Clinical AD: Role of Adhesion Molecules.Semantic proximity Read